COMMUNIQUÉS West-GlobeNewswire
-
Announcement from major shareholder
20/11/2018 - 12:07 -
Arvinas To Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018 - 12:00 -
Amarin to Present at the Evercore ISI HealthCONx Conference
20/11/2018 - 12:00 -
Completion of share capital increase
20/11/2018 - 11:18 -
Aslan Pharmaceuticals to Participate in 30th Annual Piper Jaffray Healthcare Conference
20/11/2018 - 11:00 -
Transactions in relation to share buyback program
20/11/2018 - 10:54 -
Orphazyme to present at Redeye Life Science Day
20/11/2018 - 10:18 -
FIT Biotech Oy: FIT Biotech in Sijoitus Invest event on 22 November 2018
20/11/2018 - 08:30 -
New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted
20/11/2018 - 08:30 -
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Initiation of Phase 2 Clinical Trial to Evaluate Tedopi® in Combination with Opdivo® (nivolumab) in Pancreatic Cancer
20/11/2018 - 08:00 -
Rule 2.9 Announcement
20/11/2018 - 08:00 -
DBV Technologies Presents Data at ACAAI 2018 on Investigational Viaskin Peanut for the Treatment of Peanut-Allergic Children
20/11/2018 - 07:31 -
DBV Technologies présente à l'ACAAI 2018 des données relatives à Viaskin Peanut, un médicament expérimental pour le traitement de l'allergie à l'arachide chez les enfants
20/11/2018 - 07:31 -
Innate Pharma appoints experts to new Strategic Advisory Board
20/11/2018 - 07:01 -
Innate Pharma nomme son nouveau Conseil Stratégique composé d'experts en immuno-oncologie
20/11/2018 - 07:01 -
Avivagen Announces Clarification to Press Release Issued November 19, 2018
20/11/2018 - 01:20 -
Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder
20/11/2018 - 00:46 -
R1 RCM to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018 - 00:12 -
Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule and Intention to Initiate Patient Studies in Multiple Indications in Collaboration With Sanofi
19/11/2018 - 22:30
Pages